Medindia
Medindia LOGIN REGISTER
Advertisement

TPI Receives SFDA Approval for Its Anti-Diabetic Drug Gliclazide

Friday, May 13, 2011 General News
Advertisement

For more information, please contact:

    James Jiayuan Tong M.D. Ph.D.

    Chief Financial Officer, Chief Business & Development Officer

    Director

    Tianyin Pharmaceutical Co., Inc.

    Web:     http://www.tianyinpharma.com

    Email:   [email protected]

    Tel:     +86-28-8551-6696 (Chengdu, China)

               +86-134-3655-0011 (China)

               +1-949-350-6999 (U.S.)

    Address: 23rd Floor, Unionsun Yangkuo Plaza

             No. 2, Block 3, South Renmin Road

             Chengdu, 610041

             China

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close